Induction of inflammatory cytokines

"Induction of inflammatory cytokines" is not a specific molecule or receptor but rather describes a **biological process** in which immune cells such as macrophages and helper T cells secrete signaling proteins called **inflammatory cytokines**. These molecules—including interleukin 1 (IL‑1), IL‑6, tumor necrosis factor alpha (TNF‑α), interferon gamma (IFNγ), and others—play central roles in initiating and regulating the body’s inflammatory response to infection, injury, or other stimuli[1][3][4]. The process is essential for host defense but can contribute to chronic diseases if dysregulated. Therapies often target individual cytokines or their receptors rather than the general process of "induction"[1][3]. --- **Notes:** • "Induction of inflammatory cytokines" refers to an event or pathway outcome—not a discrete molecular entity like a receptor, enzyme, transporter, etc., so it is not considered a therapeutic target itself[1][3]. Instead, individual **cytokines** such as TNF‑α or IL‑6 are recognized targets. • No canonical abbreviation exists for this phrase; it is not standard nomenclature for any single protein/gene/receptor. • There are no direct drugs that interact with "induction of inflammatory cytokines" as an entity; instead, drugs may inhibit specific pro-inflammatory cytokines or their receptors—for example monoclonal antibodies against TNF‑α ("anti-TNF agents") used in autoimmune diseases[1]. • Mechanisms of action and biomarkers pertain to individual pro-inflammatory cytokine targets. • Safety concerns relate to targeting specific pathways/cytokines—such as increased risk of infection when suppressing immune responses—but do not apply directly to this non-specific term. In summary: This entry should be flagged as incorrect because it does not refer to a single molecular target but rather describes an immunological process involving multiple molecules[1][3].

Other names

Pro-inflammatory cytokine inductionCytokine upregulationInflammatory cytokine production